Forum Financial Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$891K Buy
7,049
+28
+0.4% +$3.69K 0.01% 142
2026
Q1
$979K Sell
7,021
-9,759
-58% -$1.37M 0.01% 127
2025
Q4
$2.06M Buy
16,780
+14
+0.1% +$1.7K 0.03% 141
2025
Q3
$1.86M Sell
16,766
-479
-3% -$54.4K 0.03% 143
2025
Q2
$1.91M Buy
17,245
+6
+0% +$639 0.03% 129
2025
Q1
$1.93M Sell
17,239
-6,286
-27% -$649K 0.03% 124
2024
Q4
$2.17M Buy
23,525
+4,867
+26% +$438K 0.04% 109
2024
Q3
$1.56M Buy
18,658
+24
+0.1% +$1.83K 0.03% 136
2024
Q2
$1.28M Buy
18,634
+4,259
+30% +$284K 0.02% 146
2024
Q1
$1.05M Sell
14,375
-1,401
-9% -$108K 0.02% 183
2023
Q4
$1.28M Buy
15,776
+196
+1% +$15.3K 0.02% 137
2023
Q3
$1.17M Buy
15,580
+76
+0.5% +$5.85K 0.03% 141
2023
Q2
$1.19M Buy
15,504
+9,075
+141% +$724K 0.03% 137
2023
Q1
$533K Buy
6,429
+80
+1% +$6.63K 0.02% 248
2022
Q4
$545K Sell
6,349
-66
-1% -$5.23K 0.02% 234
2022
Q3
$396K Sell
6,415
-14
-0.2% -$883 0.02% 273
2022
Q2
$397K Sell
6,429
-4,619
-42% -$286K 0.02% 282
2022
Q1
$656K Sell
11,048
-36
-0.3% -$2.3K 0.03% 194
2021
Q4
$805K Buy
+11,084
New +$763K 0.04% 155

Other funds holding GILD

Forum Financial Management's GILD Position: Q2 2026 in Review

Forum Financial Management increased its Gilead Sciences (GILD) stake by 0.4% in Q2 2026, buying an estimated $3.69K and bringing the position to 7,049 shares worth $891K. The position accounts for 0.01% of the portfolio, ranked #142.

Forum Financial Management first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.17M in Q4 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Forum Financial Management held 7,049 shares of Gilead Sciences worth $891K as of Q2 2026.
  • Forum Financial Management bought 28 Gilead Sciences shares in Q2 2026, an estimated $3.69K.
  • Gilead Sciences made up 0.01% of Forum Financial Management's portfolio in Q2 2026, its #142 holding.
  • Forum Financial Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Forum Financial Management's Gilead Sciences position peaked at $2.17M in Q4 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Forum Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.